نتایج جستجو برای: gastrointestinal stromal tumors gist

تعداد نتایج: 306212  

2011
Christin A. Knowlton Luther W. Brady Rebecca C. Heintzelman

Gastrointestinal stromal tumors (GISTs) are uncommon mesenchymal tumors of the gastrointestinal tract. Up to one-third of GISTs are malignant with a high rate of metastasis. Surgical resection is the mainstay of care for patients with resectable disease. Imatinib mesylate, a selective tyrosine kinase inhibitor, is the current standard of care for GISTs that cannot be completely resected or in c...

2015
Aderemi Oluyemi Samuel Keshinro Abimbola Jimoh Philip Oshun

Documented reports of gastrointestinal stromal tumors (GIST) are relatively few in the sub-Saharan continent. The body of evidence points towards anal wall involvement being a rarity indeed. In this article we document a 61 year old Nigerian man who presented with bleeding per rectum and in whom the histological features (including immunohistochemistry) of the biopsied anal lesion was GIST.

Journal: :World Journal of Surgical Oncology 2008
Dritan Pasku Apostolos Karantanas Elpida Giannikaki Maria Tzardi Emmanouil Velivassakis Pavlos Katonis

BACKGROUND The location of gastrointestinal stromal tumors (GIST) outside of the gastrointestinal system is a rare event. CASE PRESENTATION A 56-year old woman presented with a GIST of the pelvis was misdiagnosed and treated as a uterine leiomyosarcoma. The diagnosis was made after the CD117 (KIT) positivity in the biopsy of the excised bowel mass four years from the first presentation. Durin...

2011
Theodosios Theodosopoulos Dionysios Dellaportas Vasiliki Psychogiou Konstantinos Gennatas Agathi Kondi-Pafiti Georgios Gkiokas Ioannis Papaconstantinou Georgios Polymeneas

Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms of the gastrointestinal tract (1%), and stomach is the most common location involved. However, the co-existence of gastric adenocarcinoma and GIST is very rare. A case of an 80-year-old male with a simultaneous presentation of a gastric adenocarcinoma and GIST is presented. Various hypotheses have been proposed in order to e...

Journal: :Ulusal cerrahi dergisi 2013
Kürşat Rahmi Serin Metin Keskin Mine Güllüoğlu Ali Emre

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. They can arise from any part of the tract as well as the omentum, mesentery or retroperitoneum. In this study, we present a case of a GIST originating from an extraordinary site, the pancreas. Evaluation of 30-year-old man with complaints of abdominal distension revealed a cystic, dista...

Journal: :Global journal of health science 2015
Nilay Karaca Yasam Kemal Akpak Zeynep Tatar Gonca Batmaz Aslihan Erken

Gastrointestinal stromal tumors (GISTs) are rare tumor of the gastrointestinal tract. GISTs occur in the entire gastrointestinal tract and may also arise from the retroperitoneum, omentum and mesenteries. They are originated from gastrointestinal pacemaker cells (Cajal's interstitial cells) and range from benign tumors to sarcomas at all sites of occurrence. Diagnosis of GIST could be deceptive...

Journal: :Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2002

2015
Kandukuri Mahesh Kumar Chintakindi Sravan Krishna Reddy Shashi Kiran

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal (GI) tract. Most of the cases are located in the stomach followed by the small intestine. They arise from the interstitial cells of cajal, which are loc Malignant GISTs are rare type of tumors in GIT. Small intestine GIST is more likely to be malignant compared to stomach. Here we reported suc...

Journal: :Gastrointestinal stromal tumor 2022

Background and Objective: Targeting KIT PDGFRA with traditional tyrosine kinase inhibitors (TKIs) such as imatinib, sunitinib regorafenib has revolutionized the treatment prognosis of patients diagnosed locally advanced metastatic gastrointestinal stromal tumors (GISTs) but resistance to those therapies represents a major challenge in management progression disease after third line. In this rev...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید